P
Peter C. Taylor
Researcher at University of Oxford
Publications - 397
Citations - 19020
Peter C. Taylor is an academic researcher from University of Oxford. The author has contributed to research in topics: Rheumatoid arthritis & Arthritis. The author has an hindex of 63, co-authored 359 publications receiving 16347 citations. Previous affiliations of Peter C. Taylor include HealthPartners & University of Cambridge.
Papers
More filters
Journal Article
Microarray Pathway Analysis Comparing Baricitinib and Adalimumab in Moderate to Severe Rheumatoid Arthritis Patients, from a Phase 3 Study
Paul Emery,Peter C. Taylor,M. Weinblatt,Yoshiya Tanaka,E.C. Keystone,Ernst R. Dow,Richard E. Higgs,William L. Macias,Guilherme Rocha,Terence Rooney,Douglas E Schlichting,Steven H. Zuckerman,I. McInnes +12 more
Journal ArticleDOI
Contrast enhancement imaging in coronary arteries in patients with systemic lupus erythematosus
Valentina O. Puntmann,David D'Cruz,Peter C. Taylor,Tarique Hussain,Andreas Indermuehle,Britta Butzbach,René M. Botnar,Eike Nagel +7 more
TL;DR: Subclinical coronary artery involvement in patients with systemic lupus erythematous (SLE) by contrast enhanced inversion recovery (CE-IR) coronary magnetic resonance imaging is examined.
Journal ArticleDOI
Mode of administration in rheumatoid arthritis treatments: an exploration of patient preference for an 'ideal treatment'
Peter C. Taylor,Rieke Alten,J Jesus Gomez-Reino,Roberto Caporali,Philippe Bertin,L Grant,E Brohan,J Wells,Radu Vasilescu,M. Tarallo +9 more
Proceedings ArticleDOI
Sat0102 association between baseline haemoglobin levels and radiographic joint damage progression in patients with rheumatoid arthritis treated with baricitinib or standard of care
B. Moeller,Patrick Durez,Axel Finckh,Pedro Lopez-Romero,Clementine Perrier,Francesco De Leonardis,Inmaculada de la Torre,Peter C. Taylor +7 more
TL;DR: Overall, RA-BEGIN and RA-BEAM patients with higher baseline Hb were less likely to show CFB in mTSS >SDC and BARI 4-mg once daily on structural damage progression at 52 wks, independent of other factors included in the MLR model.
Journal Article
Myocardial revascularization: evolution of a surgical procedure.
Delos Cosgrove,Bruce W. Lytle,Carl C. Gill,Leonard R. Golding,Robert W. Stewart,Peter C. Taylor,Floyd D. Loop +6 more
TL;DR: With more complete revascularization and greater use of the internal mammary artery, the prospects for long-term survival and palliation have improved.